ROBOT

  • Research type

    Research Study

  • Full title

    ROBOT: Rome foundation research institute biomarker and phenotyping project

  • IRAS ID

    348227

  • Contact name

    Imran Aziz

  • Contact email

    imran.aziz1@nhs.net

  • Sponsor organisation

    Sheffield Teaching Hospitals NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    2 years, 5 months, 1 days

  • Research summary

    Functional gastrointestinal disorders, or disorders of gut-brain interaction (DGBI) are currently diagnosed by use of the Rome IV criteria, consisting of a combination of symptoms and the absence of abnormal findings on a minimal number of clinical tests. The pathophysiology of DGBI is incompletely understood, but the current hypothesis is that they are caused by abnormalities of the brain-gut axis, including abnormalities within the GI tract, in different parts of the nervous system and/or in the communication between the gut and the brain. Recent research suggests that abnormalities detected in faecal, blood, urine, or in physiological / behavioural tests can be associated with subsets of patients with DGBI.

    By using a combination of symptoms, the diagnostic accuracy and predictive ability of the diagnostic model has been improved.

    In the UK the aim of this research project is to develop a collection of “clinical phenotypes” of patients with gastrointestinal disorders.
    This will be achieved by;
    1. Participants completing the questionnaire (RFRI phenotyping tool©)
    2. Uploading de-identified clinical data to help better profile the clinical case as presented within the questionnaire data.

  • REC name

    South Central - Hampshire A Research Ethics Committee

  • REC reference

    25/SC/0235

  • Date of REC Opinion

    14 Jul 2025

  • REC opinion

    Further Information Favourable Opinion